background
west
nile
viru
wnv
molecular
detect
conduct
grow
number
laboratori
degre
profici
may
vari
extern
qualiti
control
need
method
conduct
intern
qualiti
assur
studi
wnv
molecular
detect
particip
laboratori
test
noninfecti
sampl
inactiv
heat
gamma
irradi
particip
receiv
code
lyophil
sampl
contain
wnv
genet
lineag
rna
copiesml
sampl
contain
heterolog
flavivirus
neg
sampl
result
thirti
laboratori
particip
averag
laboratori
achiev
detect
probabl
copiesml
onward
probit
analysi
ci
copiesml
lineag
detect
equal
effici
lineag
strain
detect
significantli
lower
rate
particip
abl
detect
sampl
contain
copiesml
three
laboratori
gener
falseposit
result
neg
sampl
six
laboratori
report
correct
strain
identif
sampl
contain
nonwnv
flavivirus
observ
signific
posit
correl
capabl
detect
nonwnv
flavivirus
detect
wnv
lineag
conclus
particip
show
good
perform
detect
lineag
wnv
predomin
viru
northern
hemispher
inabl
laboratori
detect
even
highli
concentr
lineag
wnv
downgrad
overal
outcom
lineag
materi
receiv
studi
provid
laboratori
necessari
templat
improv
assay
materi
otherwis
hard
obtain
repres
wnv
strain
genet
lineag
heterolog
flavivirus
obtain
vero
cell
cultur
day
infect
strain
compris
genbank
access
number
genbank
access
number
wnvkunjin
mn
person
observ
supernat
heat
h
gammairradi
kgi
infect
exclud
reinocul
vero
cell
cultur
subsequ
passag
test
sampl
gener
dilut
inactiv
viru
stock
solut
human
freshfrozen
plasma
test
confirm
neg
hepat
b
viru
hepat
c
viru
wnv
dilut
enrich
plasma
divid
aliquot
frozen
lyophil
sampl
lot
redissolv
quantifi
triplic
realtim
rtpcr
realart
westnil
viru
qiagen
diagnost
three
addit
sampl
contain
mixtur
heterolog
flavivirus
also
includ
mix
done
challeng
specif
wnv
assay
mani
strain
possibl
sampl
contain
dengu
virus
denv
type
atcc
sampl
contain
yellow
fever
viru
vaccin
strain
tickborn
enceph
viru
strain
sampl
contain
st
loui
enceph
viru
atcc
japanes
enceph
viru
atcc
sampl
process
inactiv
method
describ
wnv
test
sampl
quantif
done
publish
unpublish
inhous
realtim
rtpcr
assay
content
concentr
individu
sampl
list
tabl
lyophil
test
sampl
ship
ambient
temperatur
particip
laboratori
particip
receiv
code
panel
sampl
contain
wnv
rna
copiesml
sampl
contain
heterolog
flavivirus
neg
sampl
tabl
particip
ask
use
routin
setup
molecular
assay
specif
diagnosi
acut
wnv
infect
analyz
materi
ask
detect
type
flavivirus
individu
sampl
first
determin
fraction
particip
laboratori
detect
viru
fig
fraction
plot
respect
viru
concentr
sampl
analyz
probit
analysi
n
replic
datum
point
per
concentr
except
outlier
sampl
posit
rate
sampl
correspond
exactli
concentrationdepend
respons
rate
calcul
doserespons
model
probit
analysi
p
outlier
elimin
hypothet
averag
laboratori
achiev
detect
probabl
copi
rnaml
sampl
onward
ci
copiesml
outlier
sampl
member
panel
belong
wnv
genet
lineag
strain
sampl
hit
rate
less
half
rate
predict
regress
model
laboratori
lineag
sampl
could
detect
although
lineag
sampl
time
less
viru
copiesml
test
posit
wnvkunjin
outlier
within
lineag
design
lineag
genotyp
bia
observ
wnvkunjin
detect
rate
correspond
well
doserespons
model
low
viru
concentr
copiesml
fig
c
mention
howev
make
direct
comparison
detect
rate
genotyp
addit
signific
differ
observ
detect
rate
north
american
wnv
prototyp
strain
wnv
strain
isol
anim
franc
strain
belong
lineag
apprais
perform
individu
laboratori
defin
profici
criteria
first
sampl
contain
copi
viral
rnaml
correctli
detect
posit
tabl
concentr
chosen
well
within
detect
interv
publish
commerci
rtpcr
assay
wnv
eg
second
falseposit
result
allow
neg
sampl
appli
criteria
laboratori
pass
minimum
requir
success
particip
laboratori
fail
lack
sensit
falseposit
result
tabl
six
success
laboratori
also
detect
low
copi
number
sampl
contain
wnvkunjin
copiesml
two
laboratori
miss
profici
criteria
copiesml
lineag
sampl
detect
nine
laboratori
fail
detect
lineag
sampl
detect
sampl
correctli
one
laboratori
miss
hightit
sampl
omiss
may
caus
handl
error
remain
laboratori
miss
sampl
one
laboratori
provid
correct
result
three
sampl
test
panel
contain
heterolog
flavivirus
contain
viru
tabl
five
laboratori
gener
falseposit
wnv
result
sampl
falseposit
test
result
per
laboratori
four
falseposit
result
occur
sampl
contain
heterolog
flavivirus
six
laboratori
correctli
identifi
heterolog
flavivirus
viruscontain
sampl
signific
posit
correl
exist
capabl
laboratori
detect
heterolog
flavivirus
abil
detect
lineag
sampl
ttest
p
one
earlier
studi
anova
analysi
identifi
use
commerci
test
product
sever
acut
respiratori
syndrom
coronaviru
technic
factor
posit
influenc
laboratori
perform
appli
statist
test
current
dataset
identifi
signific
advantag
possibl
small
number
particip
use
commerci
assay
studi
n
nevertheless
user
commerci
product
among
best
perform
detect
lineag
tabl
signific
influenc
laboratori
perform
found
associ
use
realtim
pcr
columnbas
rna
extract
method
roch
qiagen
autom
rna
prepar
popular
rtpcr
protocol
molecular
detect
wnv
becom
increasingli
import
task
eqa
therefor
necessari
compar
earlier
eqa
studi
emerg
agent
ebola
lassa
pox
sever
acut
respiratori
syndrom
virus
studi
overal
diagnost
perform
wnv
appear
disappoint
technic
point
view
much
lower
detect
limit
rang
copiesml
achiev
rtpcr
particip
inde
reach
concentr
averag
laboratori
howev
effici
small
number
particip
pass
rather
easi
set
profici
criteria
critic
problem
maximum
sensit
requir
clinic
case
enceph
blood
screen
test
reservoir
compon
mosquito
hand
low
success
rate
studi
mainli
caus
limit
detect
wnv
lineag
without
lineag
sampl
particip
would
pass
profici
criteria
lineag
far
preval
gener
northern
hemispher
particular
conceiv
mani
particip
may
design
assay
accord
geograph
locat
situat
would
accept
set
sever
laboratori
may
detect
lineag
broadrang
flaviviru
assay
suggest
observ
correl
nonwnv
flaviviru
detect
lineag
result
view
recent
find
presenc
lineag
wnv
potenti
new
lineag
europ
import
use
broadrang
assay
obviou
least
refer
laboratori
level
broadrang
flaviviru
assay
routin
appli
parallel
specif
wnv
detect
present
studi
show
eqa
adequ
necessari
identifi
shortcom
diagnost
profici
rare
pathogen
wnv
eqa
furthermor
provid
critic
viru
materi
requir
improv
adjust
diagnost
assay
sampl
use
studi
avail
european
network
diagnost
import
viral
diseas
futur
refer
